US Food and Drug Administration
Updated 7 weeks ago
Neuropathy Device Maker Files
Diabetes Health Staff |
Apr 24, 2012 |
NeuroMetrix, Inc., a Massachusetts-based medical device company, has filed a 510(k) form with the US Food and Drug Administration for the SENSUSTM, a pain therapy device for people who suffer diabetic neuropathy. A 510(k) is a "premarket notification" of a company's intent to market a medical product. The FDA then tests the product and provides feedback to the manufacturer. Once the FDA clears the product, its maker can introduce it to the US market.
New Type 2 Drug Targets Blood Sugar and Cholesterol
Clay Wirestone |
Dec 10, 2011 |
Drug company Merck aims to give people with type 2 diabetes two treatments for the price of one. The new therapy, called Juvisync, was just approved by the US Food and Drug Administration. It's not a radical new treatment, but instead a helpful combination of two familiar standbys: Juvisync unites the active ingredients in blood sugar-lowering Januvia and cholesterol-lowering Zocor in a single tablet.
Fatal error: Call to a member function getUrl() on a non-object in /home/diabetes/public_html/browse.php on line 54